摘要
抗肿瘤生物类似药在肿瘤临床治疗中发挥着重要作用,如何合理应用生物类似药是临床实践必须面对的问题。重庆专家重点探讨了抗肿瘤生物类似药的有效性、安全性、适应证外推及参照药转换问题,对其在临床应用上具有指导意义。
Anti-tumor biosimilars are playing an important role in the clinical treatment of tumors.How to reasonably use biosimilars is a problem that must be faced in clinical practice.Discussion of Chongqing experts focused on the effectiveness,safety,indication extrapolation and conversion between anti-tumor biosimilars and reference drugs,which has guiding significance in clinical application.
作者
单锦露
孙建国
阮志华
任必勇
杨志祥
李毅
田福华
康保国
赵晓辉
刘作金
南映瑜
邓媛
朱宇熹
王东林
陈正堂
王东
SHAN Jinlu;SUN Jianguo;RUAN Zhihua;REN Biyong;YANG Zhixiang;LI Yi;TIAN Fuhua;KANG Baoguo;ZHAO Xiaohui;LIU Zuojin;NAN Yingyu;DENG Yuan;ZHU Yuxi;WANG Donglin;CHEN Zhengtang;WANG dong(Daping Hospital,Army Medical University,Chongqing 400042,China;Xinqiao Hospital,Army Medical University,Chongqing 400037,China;Southwest Hospital,Army Medical University,Chongqing 400038,China;Three Gorges Central Hospital Affiliated to Chongqing University,Chongqing 5001014,China;Chongqing Traditional Chinese Medicine Hospital,Chongqing 400011,China;Beibei Traditional Chinese Medical Hospital,Chongqing 400700,China;People′s Hospital of Jiulongpo District,Chongqing 400050,China;The First People′s Hospital of Chongqing Liang Jiang New Area,Chongqing 401147,China;The Ninth People′s Hospital of Chongqing,Chongqing 400700,China;The Second Affiliated Hospital of Chongqing Medical University,Chongqing 400067,China;Chongqing University Cancer Hospital,Chongqing 400030,China;Chongqing Emergency Medical Center/the Fourth People′s Hospital of Chongqing 400010,China;Jinshan Hospital,the First Affiliated Hospital of Chongqing Medical University,Chongqing 401120,China)
出处
《重庆医学》
CAS
2020年第22期3685-3687,共3页
Chongqing medicine
关键词
肿瘤
生物类似药
有效性
安全性
适应证
专家共识
neoplasms
biosimilars
effectiveness
safety
indications
expert consensus